Transient hyperphosphatasemia of infancy and early childhood (THI) is characterized by a temporary isolated elevation of serum alkaline phosphatase activity (ALP), predominantly its bone or liver isoform, in either sick or healthy children under 5 years of age. Return to normal ALP levels usually occurs within four months. Spontaneous rise of ALP might concern the physician, especially when treating seriously ill children. However, THI is considered a benign biochemical disorder with no clinical consequences. Some existing reports support the hypothesis that THI is a result of increased bone turnover. We present evidence of normal bone turnover in two children with THI. In a one-year-old girl and a boy of the same age, high ALP levels (31 and 109 µkat/L, respectively) were accidentally detected. The children had no signs of metabolic bone disease or of liver disease. The high ALP levels returned to normal in two months, thus fulfilling the diagnosis of THI. In both patients, serum parathyroid hormone and bone turnover markers, serum CrossLaps, and serum osteocalcin were neither elevated, nor did these markers follow the ALP dynamics, thus reflecting normal bone turnover in THI. Children with THI should be spared from extensive investigations and unnecessary vitamin D treatment.

University of Pardubice Pardubice Hospital and Faculty of Health Studies Pediatrics Pardubice Czech Republic

Zobrazit více v PubMed

Kraut JR, Metrick M, Maxwell NR, Kaplan MM. Isoenzyme studies in transient hyperphosphatasemia of infancy. Ten new cases and a review of the literature. Am J Dis Child. 1985;139:736–740. PubMed

Stein P, Rosalki SB, Foo AY, Hjelm M. Transient hyperphosphatasemia of infancy and early childhood: clinical and biochemical features of 21 cases and literature review. Clin Chem. 1987;33:313–318. PubMed

Kutilek S, Bayer M. Transient hyperphosphatasemia - where do we stand. Turk J Pediatr. 1999;41:151–160. PubMed

Dodig S, Demirovic J, Jelcic Z, Richter D, Cepelak I, Zrinski Topic R, Petrinovic R. Transient hyperphosphatasemia in an infant with bronchiolitis and pneumonia. Eur J Med Res. 2008;13:536–538. PubMed

Dori N, Levi L, Stam T, Sukhotnik I, Shaoul R. Transient hyperphosphatasemia in children revisited. Pediatr Int. 2010;52:866–871. PubMed

Teitelbaum JE, Laskowski A, Barrows FP. Benign trasnient hyperphosphatasemia in infants and children: a prospective cohort. J Pediatr Endocrinol Metab. 2011;24:351–353. PubMed

Eymann A, Cacchiarelli N, Alonso G, Llera J. Benign transient hyperphosphatasemia of infancy. A common scenario, a big concern for the pediatrician. J Pediatr Endocrinol Metab. 2010;23:927–930. PubMed

Crofton PM. What is the cause of benign transient hyperphosphatasemia. Clin Chem. 1988;34:335–340. PubMed

Kutilek S, Stepan JJ, Dolezalova P, Kesslerova Z. Transient hyperphosphatasaemia of infancy and early childhood - The Ulysses syndrome. (in Czech) Cas Lek Ces. 1989;128:375–377. PubMed

Bzduch V, Behulova D. Increased acid phosphatase in isolated transient hyperphosphatasemia. (In Slovak) Cas Lek Ces. 1992;131:271–272. PubMed

Stepan JJ, Kutilek S, Bayer M. Transient hyperphosphatasaemia in infancy associated with an increased urinary hydroxyproline excretion. Clin Chim Acta. 1995;233:115–118. PubMed

Kruse K, Reiss I, Inderrieden D. Biochemical markers of bone turnover in diseases of extracellular calcium and phosphate metabolism. In: Schonau E, editor. Paediatric Osteology: New Developments in Diagnostics and Therapy. Amsterdam: Elsevier Science; 1996. pp. 203–220.

Kruse K. Normal bone turnover in isolated hyperphosphatasemia. J Pediatr. 1985;106:946–948. PubMed

Huh SY, Feldman HA, Cox JE, Gordon CM. Prevalence of transient hyperphosphatasemia among healthy infants and toddlers. Pediatrics. 2009;124:703–709. PubMed PMC

Garty BZ, Nitzan M. Benign transient hyperphosphatasemia. Isr J Med Sci. 1994;30:66–69. PubMed

Schwab M, Schmidt-Gayk H, Ruder H. Transient hyperphosphatasaemia in a 4-year-old boy after successful kidney transplantation. Nephrol Dial Transplant. 1997;12:1745–1749. PubMed

Phan V, Clermont MJ. Transient hyperphosphatasaemia in a 7-year-old boy following renal transplantation. Nephrol Dial Transplant. 1998;13:2428–2429. PubMed

Cachat F, Guignard JP. Transient hyperphosphatasemia in a renal transplant patient. Acta Paediatr. 1999;88:1046–1047. PubMed

Ranchin B, Villard F, Andre JL, Canterino I, Said MH, Boisson RC, Lachaux A, David L, Cochat P. Transient hyperphosphatasemia after organ transplantation in children. Pediatr Transplant. 2002;6:308–312. PubMed

Kutilek S, Skalova S, Vethamuthu J, Geier P, Feber J. Transient hyperphosphatasemia in pediatric renal transplant - is there a need for concern and when. Pediatr Transplant. 2012;16:5–9. PubMed